Xin Liu

Title: Innovations of Inventor Xin Liu

Introduction

Xin Liu is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of transgenic mammals. Her work focuses on the manipulation of erythropoietin and its receptors, which has implications for medical research and therapeutic applications.

Latest Patents

Xin Liu holds a patent titled "Transgenic Mammals Lacking Expression of Erythropoietin or of Erythropoietin Receptor, Transgenic Mammals Expressing Chimeric Erythropoietin Receptors, Constructs for Producing the Transgenic Mammals and Uses Therefor." This patent describes transgenic nonhuman mammals, such as transgenic mice, that lack erythropoietin expression and have deleted erythropoietin receptors. The patent also covers constructs useful for producing these transgenic mammals, embryonic stem cells containing the constructs, and methods for identifying erythropoietin mimics or mimetics.

Career Highlights

Throughout her career, Xin Liu has demonstrated a commitment to advancing scientific knowledge and innovation. Her research has contributed to a better understanding of erythropoietin's role in various biological processes. She has been recognized for her work in the field and continues to be an influential figure in biotechnology.

Collaborations

Xin Liu has collaborated with notable scientists, including Hong Wu and Harvey F Lodish. These collaborations have further enhanced her research and contributed to the advancement of knowledge in her field.

Conclusion

Xin Liu is a distinguished inventor whose work in transgenic mammals has the potential to impact medical research significantly. Her innovative approaches and collaborations highlight her contributions to biotechnology and the scientific community.